Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-Current Debt (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Non-Current Debt data on record, last reported at $505.6 million in Q3 2025.

  • For Q3 2025, Non-Current Debt fell 10.63% year-over-year to $505.6 million; the TTM value through Sep 2025 reached $505.6 million, down 10.63%, while the annual FY2024 figure was $550.7 million, 148.4% up from the prior year.
  • Non-Current Debt reached $505.6 million in Q3 2025 per COLL's latest filing, down from $520.6 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $565.7 million in Q3 2024 and bottomed at $61.7 million in Q4 2021.
  • Average Non-Current Debt over 5 years is $332.2 million, with a median of $353.8 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: surged 544.73% in 2022, then crashed 57.13% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $61.7 million in 2021, then soared by 544.73% to $397.6 million in 2022, then plummeted by 44.23% to $221.7 million in 2023, then skyrocketed by 148.4% to $550.7 million in 2024, then decreased by 8.2% to $505.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $505.6 million in Q3 2025, $520.6 million in Q2 2025, and $535.7 million in Q1 2025.